chartexchange

NITE
The Nightview Fund
stockNYSEETF

At CloseOct 2, 2026 12:39:18 PM EDT
38.75USD+1.360%(+0.52)2,102
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
Cincinnati, Ohio, USA
Previous Close
$38.23
Beta
1.40
52-Week High
$41.00 2026-09-03
52-Week Low
$32.52 2026-03-30
SMA 50
$38.87
SMA 200
$37.11
Avg. Vol 10D
1,617
Avg. Vol 30D
3,384
Avg. Vol 90D
1,749
Relative Vol
0.62
33.48M
8.5800%
NITE Profile

Nightstar Therapeutics Ltd is a clinical-stage gene therapy company. It is focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases.

NITE Performance
PeriodPriceDateChangeBeta
1W37.922026-09-28+2.06%1.219
1M40.382026-09-04-4.14%1.294
3M37.732026-07-06+2.57%1.520
6M33.832026-04-06+14.41%1.362
1Y35.452025-10-03+9.18%1.402
2Y26.352024-10-04+46.87%—
5Y25.412019-06-06+52.32%1.407
NITE Stock Summary

The Nightview Fund (NYSE:NITE) stock price today is $38.71, and today's volume is 2,102. NITE is up 1.242% today. The 30 day average volume is 3,384. NITE market cap is $1.30B with 33.48M shares outstanding.